Systematic Optimization of the iMALDI Workflow for the Robust and Straightforward Quantification of Signaling Proteins in Cancer Cells

R: A Language and Environment for Statistical Computing

R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,706 · see citing works

Targeting the PI3K pathway in cancer: are we making headway?

Janku, F., Yap, T. A., & Meric-Bernstam, F. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.28 · Cited by 1,033 · see citing works

Data‐independent acquisition‐based SWATH‐MS for quantitative proteomics: a tutorial

Ludwig, C., Gillet, L. C. J., Rosenberger, G., Amon, S., Collins, B. C., & Aebersold, R. H. (2018) · Molecular Systems Biology · doi:10.15252/msb.20178126 · Cited by 999 · see citing works

Mass Spectrometric Quantitation of Peptides and Proteins Using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA)

Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B., Olafson, R. W., & Pearson, T. W. (2004) · Journal of Proteome Research · doi:10.1021/pr034086h · Cited by 806 · see citing works

The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry

Hoofnagle, A. N., & Wener, M. H. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.003 · Cited by 562 · see citing works

MALDI-TOF MS for the Diagnosis of Infectious Diseases

Patel, R. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.221770 · Cited by 535 · see citing works

Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma

Kuzyk, M. A., Smith, D., Yang, J., Cross, T. J., Jackson, A. M., Hardie, D. B., Anderson, N. L., & Borchers, C. H. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800540-mcp200 · Cited by 515 · see citing works

Determination of monoisotopic masses and ion populations for large biomolecules from resolved isotopic distributions

Senko, M. W., Beu, S. C., & McLaffertycor, F. W. (1995) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(95)00017-8 · Cited by 451 · see citing works

Immunohistochemistry as an Important Tool in Biomarkers Detection and Clinical Practice

Matos, L. L., Trufelli, D. C., de Matos, M. G. L., & Pinhal, M. A. D. S. (2010) · Biomarker Insights · doi:10.4137/bmi.s2185 · Cited by 442 · see citing works

A Quantitative Study of the Effects of Chaotropic Agents, Surfactants, and Solvents on the Digestion Efficiency of Human Plasma Proteins by Trypsin

Proc, J. L., Kuzyk, M. A., Hardie, D. B., Yang, J., SMITH, D. S. H., Jackson, A., Parker, C. E., & Borchers, C. H. (2010) · Journal of Proteome Research · doi:10.1021/pr100656u · Cited by 354 · see citing works

BoxCar acquisition method enables single-shot proteomics at a depth of 10,000 proteins in 100 minutes

Meier, F., Geyer, P. E., Winter, S. V., Cox, J., & Mann, M. (2018) · Nature Methods · doi:10.1038/s41592-018-0003-5 · Cited by 341 · see citing works

Portrait of the PI3K/AKT pathway in colorectal cancer

Danielsen, S. A., Eide, P. W., Nesbakken, A., Guren, T. K., Leithe, E., & Lothe, R. A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.09.008 · Cited by 326 · see citing works

Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics

Burkhart, J. M., Schumbrutzki, C., Wortelkamp, S., Sickmann, A., & Zahedi, R. P. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.11.016 · Cited by 297 · see citing works

Mass spectrometry based biomarker discovery, verification, and validation — Quality assurance and control of protein biomarker assays

Parker, C. E., & Borchers, C. H. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.006 · Cited by 238 · see citing works

Garbage in, garbage out: A critical evaluation of strategies used for validation of immunohistochemical biomarkers

O’Hurley, G., Sjöstedt, E., Rahman, A., Li, B., Kampf, C., Pontén, F., Gallagher, W. M., & Lindskog, C. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.008 · Cited by 181 · see citing works

Pragmatic issues in biomarker evaluation for targeted therapies in cancer

Gramont, A. D. E., Watson, S., Ellis, L. M., Rodon, J. A., Tabernero, J. M., de Gramont, A., & Hamilton, S. R. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.202 · Cited by 174 · see citing works

Targeted and Untargeted Proteomics Approaches in Biomarker Development

Sobsey, C. A., Ibrahim, S., Richard, V. R., Gaspar, V. P., Mitsa, G., Lacasse, V., Zahedi, R. P., Batist, G., & Borchers, C. H. (2019) · PROTEOMICS · doi:10.1002/pmic.201900029 · Cited by 174 · see citing works

A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory

Lévesque, S., Dufresne, P. J., Soualhine, H., Domingo, M.-C., Bekal, S., Lefebvre, B., & Tremblay, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144878 · Cited by 172 · see citing works

Detection of dysregulated protein-association networks by high-throughput proteomics predicts cancer vulnerabilities

Lapek, J. D., Greninger, P., Morris, R. T., Amzallag, A., Pruteanu-Malinici, I., Benes, C. H., & Haas, W. (2017) · Nature Biotechnology · doi:10.1038/nbt.3955 · Cited by 159 · see citing works

Measuring affinity constants of 1450 monoclonal antibodies to peptide targets with a microarray-based label-free assay platform

Landry, J. P., Ke, Y., Yu, G.-L., & Zhu, X. D. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.12.011 · Cited by 157 · see citing works

Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis

Li, S., Shen, Y., Wang, M., Yang, J., Lv, M., Li, P., Chen, Z., & Jin, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.16761 · Cited by 144 · see citing works

PeptidePicker: A scientific workflow with web interface for selecting appropriate peptides for targeted proteomics experiments

Mohammed, Y., Domański, D., Jackson, A., SMITH, D. S. H., Deelder, A. M., Palmblad, M., & Borchers, C. H. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.04.018 · Cited by 130 · see citing works

A Novel Differential Ion Mobility Device Expands the Depth of Proteome Coverage and the Sensitivity of Multiplex Proteomic Measurements

Pfammatter, S., Bonneil, É., McManus, F. P., Prasad, S., Bailey, D. J., Belford, M. W., Dunyach, J., & Thibault, P. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir118.000862 · Cited by 123 · see citing works

Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact

Li, L., Wei, Y., To, C., Zhu, C., Tong, J., Pham, N., Taylor, P. P., Ignatchenko, V., Ignatchenko, A., Zhang, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6469 · Cited by 115 · see citing works

Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography–Tandem Mass Spectrometry: Current State and Future Vision

Neubert, H., Shuford, C. M., Olah, T. V., Garofolo, F., Schultz, G. A., Jones, B. R., Amaravadi, L., Laterza, O. F., Xu, K., & Ackermann, B. L. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvz022 · Cited by 109 · see citing works

Can LC and LC-MS ever replace immunoassays?

Cross, T. G., & Hornshaw, M. P. (2016) · Journal of Applied Bioanalysis · doi:10.17145/jab.16.015 · Cited by 91 · see citing works

Simultaneous Measurement of 10,000 Protein-Ligand Affinity Constants Using Microarray-Based Kinetic Constant Assays

Landry, J. P., Fei, Y., & Zhu, X. D. (2011) · Assay and Drug Development Technologies · doi:10.1089/adt.2011.0406 · Cited by 80 · see citing works

A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research

Faria, S. S., Morris, C. F. M., Silva, A. R., da Fonseca, M. P., Forget, P., Castro, M. S., & Fontes, W. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00013 · Cited by 60 · see citing works

Targeting Peptide Termini, a Novel Immunoaffinity Approach to Reduce Complexity in Mass Spectrometric Protein Identification

Hoeppe, S., Schreiber, T. D., Planatscher, H., Zell, A., Templin, M. F., Stoll, D., Joos, T. O., & Poetz, O. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002857 · Cited by 47 · see citing works

Immuno-Matrix-Assisted Laser Desorption/Ionization Assays for Quantifying AKT1 and AKT2 in Breast and Colorectal Cancer Cell Lines and Tumors

Popp, R., Li, H., LeBlanc, A. M., Mohammed, Y., Aguilar‐Mahecha, A., Chambers, A. G., Lan, C., Poetz, O., Basik, M., Batist, G., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02934 · Cited by 35 · see citing works

Miniaturizing sample spots for matrix-assisted laser desorption/ionization mass spectrometry

Tu, T., & Gross, M. L. (2009) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2009.03.013 · Cited by 26 · see citing works

Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic Data

Blank‐Landeshammer, B., Richard, V. R., Mitsa, G., Marques, M., LeBlanc, A. M., Kollipara, L., Feldmann, I., du Tertre, M. C., Gambaro, K., McNamara, S., et al. (2019) · Cancers · doi:10.3390/cancers11121907 · Cited by 25 · see citing works

How iMALDI can improve clinical diagnostics

Popp, R., Basik, M., Spatz, A., Batist, G., Zahedi, R. P., & Borchers, C. H. (2018) · The Analyst · doi:10.1039/c8an00094h · Cited by 19 · see citing works

Prognostic significance of phosphoinositide 3-kinase p110α and p110β isoforms in non-small cell lung cancer.

Lee, J. S., Lee, H. W., Lee, E. H., Park, M.-I., Lee, J. S., Kim, M.-S., Kim, S., Kim, T. G., Nam, H., Hwang, S. W., et al. (2018) · PubMed Central · Cited by 3 · see citing works

Prospective on Imaging Mass Spectrometry in Clinical Diagnostics

Moore, J. L., Patterson, N. H., Norris, J. L., & Caprioli, R. M. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100576 · Cited by 47 · see citing works

Using Two Peptide Isotopologues as Internal Standards for the Streamlined Quantification of Low-Abundance Proteins by Immuno-MRM and Immuno-MALDI

Ibrahim, S., Froehlich, B. C., Aguilar‐Mahecha, A., Aloyz, R. S., Poetz, O., Basik, M., Batist, G., Zahedi, R. P., & Borchers, C. H. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02157 · Cited by 15 · see citing works

Precise Quantitation of PTEN by Immuno-MRM: A Tool To Resolve the Breast Cancer Biomarker Controversy

Ibrahim, S., Lan, C., Chabot, C., Mitsa, G., Buchanan, M., Aguilar‐Mahecha, A., Elchebly, M., Poetz, O., Spatz, A., Basik, M., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00975 · Cited by 12 · see citing works

Immuno-MALDI-MS for Accurate Quantitation of Targeted Peptides from Volume-Restricted Samples

Sobsey, C. A., Froehlich, B. C., Batist, G., & Borchers, C. H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2409-8_13 · Cited by 4 · see citing works

Sequencing of <scp>d</scp>/<scp>l</scp>-DNA and XNA by Templated-Synthesis

Joshi, S., Romanens, P., & Winssinger, N. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c00708 · Cited by 4 · see citing works

Accelerating Drug Discovery with Ultrahigh‐Throughput MALDI‐TOF MS

Dikler, S. (2023) · doi:10.1002/9781119678496.ch12

Supplementary Methods S1 from mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA-Altered Tumors

Sobsey, C. A., Froehlich, B. C., Mitsa, G., Ibrahim, S., Popp, R., Zahedi, R. P., de Bruin, E. C., Borchers, C. H., & Batist, G. (2024) · doi:10.1158/2767-9764.26553471.v1

Supplementary Methods S1 from mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA-Altered Tumors

Sobsey, C. A., Froehlich, B. C., Mitsa, G., Ibrahim, S., Popp, R., Zahedi, R. P., de Bruin, E. C., Borchers, C. H., & Batist, G. (2024) · doi:10.1158/2767-9764.26553471

Immuno-MALDI (iMALDI) mass spectrometry for the analysis of proteins in signaling pathways

Popp, R., Li, H., & Borchers, C. H. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1516147 · Cited by 12 · see citing works

iMALDI as a tool to improve patient stratification for targeted cancer therapies

Popp, R. (2018) · UVic’s Research and Learning Repository (University of Victoria)

Abstract LB-177: Quantification of cell signaling proteins by immuno-MALDI

Popp, R., Zahedi, R. P., LeBlanc, A. M., Mohammed, Y., Aguilar‐Mahecha, A., Pötz, O., Basik, M., Batist, G., & Borchers, C. H. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-lb-177

Immuno-MALDI-MS for Accurate Quantitation of Targeted Peptides from Volume-Restricted Samples

Sobsey, C. A., Froehlich, B. C., Batist, G., & Borchers, C. H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2409-8_13 · Cited by 4 · see citing works

Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI)

Li, H., Popp, R., Frohlich, B., Chen, M. X., & Borchers, C. H. (2017) · Journal of Visualized Experiments · doi:10.3791/55933 · Cited by 15 · see citing works